POP BIO and EuBiologics’ Shingles Vaccine Enters Phase 1 Clinical Trials

EIN Presswire reported that a biotech company founded by Johnathan Lovel, POP Biotechnologies, has moved into phase one of clinical trials for their new shingles vaccine.